Breaking news

Paradromics Breaks Ground with First Human Brain-Computer Interface Implant

by News Editor

June 2, 2025

Neurotech startup Paradromics has made headlines by successfully implanting its brain-computer interface (BCI) in a human for the first time. This milestone took place at the University of Michigan, with the device being inserted and removed in a swift 20-minute procedure during epilepsy-related neurosurgery.

The Paradromics BCI strives to revolutionize communication for individuals with severe motor impairments, enabling them to use computer systems with brain signals alone. The company’s future clinical trials, set for later this year pending regulatory approval, aim to explore the technology’s long-term viability in humans.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

“We’re incredibly excited to move into the clinical stage,” said Matt Angle, founder and CEO of Paradromics. “This success is a testament to our commitment to enhancing BCI technologies.”

While Paradromics’ BCI awaits official clearance from the FDA, this achievement underscores a promising future for BCIs. The company has already demonstrated its skills in animal models, showcasing its ability to capture detailed brain activities at the neuronal level.

Paradromics joins the ranks of other pioneers such as Elon Musk’s Neuralink, Synchron, and Precision Neuroscience in driving forward the BCI space. With almost $100 million in funding and a strategic edge, Paradromics is on track to redefine neurotechnology.

The Future Forbes Realty Global Properties

Sklavenitis Cyprus Sets A New Standard For Employee-Centric Benefits

by THEFUTURE.TEAM

September 12, 2025

Investing In Human Capital

In a bold move that underscores the growing importance of human capital in today’s business landscape, Sklavenitis Cyprus has taken innovative steps to ensure its workforce is both valued and supported. The supermarket chain has introduced a policy to pay a 14th salary to all employees—including those from Papantoniou Supermarkets—cementing its status as the sole retailer in Cyprus to implement such a comprehensive benefit.

A Significant Investment In People

This initiative is far from symbolic. With an estimated total cost of €2 million, it represents a committed investment in the company’s most valuable asset—its people. By providing an additional salary, Sklavenitis reinforces a culture of inclusivity and fairness, acknowledging every employee’s contribution to its success.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Robust Benefits For Long-Term Stability

Complementary to the 14th salary, the company has launched a robust benefits program designed to address both financial and personal security. An Automatic Cost of Living Adjustment (ATA) of 12.56 per cent ensures that wages remain aligned with inflation, safeguarding real income stability for its team members.

Comprehensive Health And Life Support

Sklavenitis further enhances employee welfare through access to a Group Life and Health Insurance Plan and a Provident Fund co-funded by the employer. These measures not only provide immediate protection but also empower employees to plan confidently for the future.

Exclusive Perks And Incentives

The company extends its commitment beyond conventional benefits by offering store discounts, a birth allowance, and holiday gift vouchers valued at €100 during both Easter and Christmas. These additional perks enhance employee satisfaction and underline Sklavenitis’ people-first ethos.

A Strategy For Mutual Success

In an industry where employee engagement directly impacts customer satisfaction, Sklavenitis’ comprehensive approach stands out as both a progressive and strategic business decision. By investing in its workforce, the company not only nurtures a supportive workplace but also drives superior corporate performance, setting a new benchmark for responsible employment practices in Cyprus.